G.J. Lockbaum
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS drug development and treatment
-
- Computational Drug Discovery Methods
Papers in
-
- HIV/AIDS drug development and treatment 9
- SARS-CoV-2 and COVID-19 Research 4
-
- Hepatitis C virus research 3
- Co-authors
- Celia A. Schiffer (18 shared papers)Neşe Kurt Yılmaz (16 shared papers)E.A. Nalivaika (11 shared papers)Akbar Ali (11 shared papers)M. Henes (11 shared papers)Paul R. Thompson (3 shared papers)Archie C. Reyes (2 shared papers)Linah N. Rusere (8 shared papers)
- Journals
- Journal of Medicinal Chemistry (3 papers)ACS Medicinal Chemistry Letters (2 papers)Nature Communications (2 papers)Biochemistry (2 papers)European Journal of Medicinal Chemistry (2 papers)
- Partner nations
- United States
In The Last Decade
G.J. Lockbaum
20 papers receiving 538 citations
Peers
Comparison fields: 5 of 45
- Infectious Diseases 283
- Computational Theory and Mathematics 137
- Drug Discovery 1
- Hepatology 26
- Cancer Research 29
Countries citing papers authored by G.J. Lockbaum
This map shows the geographic impact of G.J. Lockbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.J. Lockbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.J. Lockbaum more than expected).
Fields of papers citing papers by G.J. Lockbaum
This network shows the impact of papers produced by G.J. Lockbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.J. Lockbaum. The network helps show where G.J. Lockbaum may publish in the future.
Co-authors
The 25 scholars most cited alongside G.J. Lockbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 96 | |
| 2 | 2021 | 95 | |
| 3 | 2021 | 64 | |
| 4 | 2022 | 44 | |
| 5 | 2019 | 36 | |
| 6 | 2021 | 30 | |
| 7 | 2018 | 29 | |
| 8 | 2019 | 25 | |
| 9 | 2018 | 21 | |
| 10 | 2020 | 19 | |
| 11 | 2021 | 18 | |
| 12 | 2023 | 16 | |
| 13 | 2021 | 14 | |
| 14 | 2019 | 13 | |
| 15 | 2023 | 10 | |
| 16 | 2020 | 6 | |
| 17 | 2025 | 6 | |
| 18 | 2020 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2025 | 1 |
About G.J. Lockbaum
G.J. Lockbaum is a scholar working on Infectious Diseases, Hepatology, Computational Theory and Mathematics, Cell Biology and Materials Chemistry, having authored 21 papers that have together received 545 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (9 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Hepatitis C virus research (3 papers), Computational Drug Discovery Methods (3 papers), Enzyme Structure and Function (2 papers), Cancer therapeutics and mechanisms (1 paper), Microtubule and mitosis dynamics (1 paper) and DNA and Nucleic Acid Chemistry (1 paper). The work is most often cited by research in Infectious Diseases (283 citations), Computational Theory and Mathematics (137 citations), Drug Discovery (1 citation), Hepatology (26 citations) and Cancer Research (29 citations). G.J. Lockbaum has collaborated with scholars based in United States. Frequent co-authors include Celia A. Schiffer, Neşe Kurt Yılmaz, E.A. Nalivaika, Akbar Ali, M. Henes, Paul R. Thompson, Archie C. Reyes, Linah N. Rusere, Daniel N. A. Bolon and Ronak R. Tilvawala. Their work appears in journals such as Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Nature Communications, Biochemistry and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.